(Q36649036)

English

Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients

scientific article published on June 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients (English)

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

0 references

metastatic breast cancer

1 reference

based on heuristic

inferred from title

Isabelle Ray-Coquard

2

object named as

I Ray-Coquard

0 references

6

object named as

J-Y Blay

0 references

author name string

T Bachelot

1

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

C Menetrier-Caux

3

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

M Rastkha

4

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

A Duc

5

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

language of work or name

0 references

publication date

1 June 2003

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

88

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

11

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

1721-1726

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6600956

0 references

Arterio-venous gradients of IL-6, plasma and serum VEGF and D-dimers in human cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377148

30 September 2017

The prognostic value of vascular endothelial growth factor in 574 node-negative breast cancer patients who did not receive adjuvant systemic therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377148

30 September 2017

Prognostic impact of matched preoperative plasma and serum VEGF in patients with primary colorectal carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377148

30 September 2017

Clinicoprognostic implications of increased serum levels of vascular endothelial growth factor and basic fibroblastic growth factor in early B-cell chronic lymphocytic leukaemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377148

30 September 2017

Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377148

30 September 2017

Clinical implications of circulating angiogenic factors in cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377148

30 September 2017

Prognostic value of vascular endothelial growth factor in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377148

30 September 2017

Breast cancer cell line MDA-231 stimulates osteoclastogenesis and bone resorption in human osteoclasts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377148

30 September 2017

Direct activation of oestrogen receptor-alpha by interleukin-6 in primary cultures of breast cancer epithelial cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377148

30 September 2017

Expression of interleukin 6 (IL-6) correlates with oestrogen receptor in human breast carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377148

30 September 2017

Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377148

30 September 2017

Construction and validation of a practical prognostic index for patients with metastatic breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377148

30 September 2017

Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377148

30 September 2017

Cytokine suppression of protease activation in wild-type p53-dependent and p53-independent apoptosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377148

30 September 2017

Role of interleukin-6 in the paraneoplastic inflammatory syndrome associated with renal-cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377148

30 September 2017

Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377148

30 September 2017

Nuclear factor interleukin 6 motifs mediate tissue-specific gene transcription in hypoxia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377148

30 September 2017

Stromal cells from human benign prostate hyperplasia produce a growth-inhibitory factor for LNCaP prostate cancer cells, identified as interleukin-6.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377148

30 September 2017

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377148

30 September 2017

Interleukin 6 induces the expression of vascular endothelial growth factor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377148

30 September 2017

Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377148

30 September 2017

Interleukin-6 family of cytokines and gp130

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377148

30 September 2017

Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377148

30 September 2017

The regulation of aromatase activity in breast fibroblasts: the role of interleukin-6 and prostaglandin E2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377148

28 June 2018

Simultaneous elevation in the serum concentrations of the angiogenic growth factors VEGF and bFGF is an independent predictor of poor prognosis in non-Hodgkin lymphoma: a single-institution study of 200 patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377148

20 September 2018

Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377148

20 September 2018

Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factor.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377148

20 September 2018

Prospective study of intratumoral microvessel density, p53 expression and survival in colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6600956

21 January 2018

Vascular endothelial growth factor measured in platelet poor plasma allows optimal separation between cancer patients and volunteers: a key to study an angiogenic marker in vivo?

1 reference

https://pubmed.ncbi.nlm.nih.gov/12771987

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of interleukin-6, interleukin-6 receptor, and glycoprotein 130 correlates with good prognoses for patients with breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12771987

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum interleukin 6 as a prognostic factor in patients with prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12771987

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging?

1 reference

https://pubmed.ncbi.nlm.nih.gov/12771987

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/12771987

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The interaction of cytokines in regulating oestradiol 17 beta-hydroxysteroid dehydrogenase activity in MCF-7 cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/12771987

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular endothelial growth factor is essential for initial but not continued in vivo growth of human breast carcinoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/12771987

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin 6 acts as a paracrine growth factor in human mammary carcinoma cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/12771987

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Blood platelets and serum VEGF in cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/12771987

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/12771987

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/12771987

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum VEGF levels in women with a benign breast tumor or breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12771987

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12771987

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/SJ.BJC.6600956

1 reference

https://api.fatcat.wiki/v0/release/tbngn6gyefed7jka5zaouu3xam

30 July 2022

based on heuristic

mapped directly with Wikidata item

release_tbngn6gyefed7jka5zaouu3xam

1 reference

https://api.fatcat.wiki/v0/release/tbngn6gyefed7jka5zaouu3xam

30 July 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

https://api.fatcat.wiki/v0/release/tbngn6gyefed7jka5zaouu3xam

30 July 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

https://api.fatcat.wiki/v0/release/tbngn6gyefed7jka5zaouu3xam

30 July 2022

based on heuristic

mapped directly with Wikidata item

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36649036&oldid=1801861595"